Search Results - Carrie L. Kitko

Refine Results
  1. 1
    Transplant Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia: The Cibmtr Experience

    Transplant Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia: The Cibmtr Experience by Parinda A. Mehta, Mary Eapen, Mei‐Jie Zhang, Wensheng He, Adriana Seber, Carrie L. Kitko, Gregory A. Hale, Stella M. Davies

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung

    Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung by Sameem Abedin, Gregory A. Yanik, Thomas Braun, Attaphol Pawarode, John Magenau, Steven C. Goldstein, John E. Levine, Carrie L. Kitko, Daniel R. Couriel

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation

    Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation by Gregory A. Yanik, Shin Mineishi, John E. Levine, Carrie L. Kitko, Eric S. White, Mark T. Vander Lugt, Andrew C. Harris, Thomas M. Braun, Kenneth R. Cooke

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes

    Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes by Andrew C. Harris, Carrie L. Kitko, Daniel R. Couriel, Thomas M. Braun, Sung Won Choi, John Magenau, Shin Mineishi, Attaphol Pawarode, Greg Yanik, John E. Levine

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

    Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and surviva... by Sung Won Choi, Carrie L. Kitko, Thomas Braun, Sophie Paczesny, Gregory A. Yanik, Shin Mineishi, Oleg I. Krijanovski, Dawn Jones, Joel Whitfield, Kenneth R. Cooke, Raymond J. Hutchinson, James L.M. Ferrara, John E. Levine

    Published 2008
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium

    Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium by Zachariah DeFilipp, Amin M. Alousi, Joseph A. Pidala, Paul A. Carpenter, Lynn Onstad, Sally Arai, Mukta Arora, Corey Cutler, Mary E.D. Flowers, Carrie L. Kitko, George L. Chen, Stephanie J. Lee, Betty K. Hamilton

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

    Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease by John E. Levine, Sophie Paczesny, Shin Mineishi, Thomas M. Braun, Sung Won Choi, Raymond J. Hutchinson, Dawn Jones, Yasser Khaled, Carrie L. Kitko, Daniel Bickley, Oleg I. Krijanovski, Pavan Reddy, Gregory A. Yanik, James L.M. Ferrara

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease

    Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease by Holly Miller, Thomas M. Braun, Terri Stillwell, Andrew C. Harris, Sung Won Choi, James A. Connelly, Daniel Couriel, Steven Goldstein, Carrie L. Kitko, John Magenau, Attaphol Pawarode, Pavan Reddy, Mary Mansour Riwes, Gregory A. Yanik, John E. Levine

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Parametric Response Mapping as an Indicator of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation

    Parametric Response Mapping as an Indicator of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation by Craig J. Galbán, Jennifer L. Boes, Maria Bule, Carrie L. Kitko, Daniel R. Couriel, Timothy D. Johnson, V.N. Lama, Eef D. Telenga, Maarten van den Berge, Alnawaz Rehemtulla, Ella A. Kazerooni, Michael J. Ponkowski, Brian D. Ross, Gregory A. Yanik

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-versus-Host-Disease

    Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-versus-Host-Disease by John Magenau, Xuemei Qin, Isao Tawara, Clare Rogers, Carrie L. Kitko, Matthew Schlough, Daniel Bickley, Thomas M. Braun, Pil‐Sang Jang, Kathleen P. Lowler, Dawn Jones, Sung Won Choi, Pavan Reddy, Shin Mineishi, John E. Levine, James L.M. Ferrara, Sophie Paczesny

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes

    TNF-Inhibition with Etanercept for Graft-versus-Host Disease Prevention in High-Risk HCT: Lower TNFR1 Levels Correlate with Better Outcomes by Sung Won Choi, Patrick J. Stiff, Kenneth R. Cooke, James L.M. Ferrara, Thomas M. Braun, Carrie L. Kitko, Pavan Reddy, Gregory A. Yanik, Shin Mineishi, Sophie Paczesny, David A. Hanauer, Attaphol Pawarode, Edward Peres, Tulio E. Rodriguez, Scott E. Smith, John E. Levine

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    A biomarker panel for acute graft-versus-host disease

    A biomarker panel for acute graft-versus-host disease by Sophie Paczesny, Oleg I. Krijanovski, Thomas M. Braun, Sung Won Choi, Shawn G. Clouthier, Rork Kuick, David E. Misek, Kenneth R. Cooke, Carrie L. Kitko, Angela C. Weyand, Daniel Bickley, Dawn Jones, Joel Whitfield, Pavan Reddy, John E. Levine, Samir Hanash, James L.M. Ferrara

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Exercise and Stress Management Training Prior to Hematopoietic Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902

    Exercise and Stress Management Training Prior to Hematopoietic Cell Transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902 by Paul B. Jacobsen, Jennifer Le‐Rademacher, Heather Jim, Karen L. Syrjala, John R. Wingard, Brent R. Logan, Juan Wu, Navneet S. Majhail, William A. Wood, J. Douglas Rizzo, Nancy L. Geller, Carrie L. Kitko, Edward A. Faber, Muneer H. Abidi, Susan Slater, Mary M. Horowitz, Stephanie J. Lee

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia

    Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia by Alan S. Wayne, Van Huynh, Nobuko Hijiya, Rayne H. Rouce, Patrick A. Brown, Joerg Krueger, Carrie L. Kitko, Edward Ziga, Michelle L. Hermiston, Michael K. Richards, André Baruchel, Petra Schuberth, John M. Rossi, Lang Zhou, Lovely Goyal, Rajul K. Jain, Remus Vezan, Behzad Kharabi Masouleh, Daniel W. Lee

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML

    FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML by Yan Song, John Magenau, Y Li, Thomas Braun, Lin Chang, Dale L. Bixby, David A. Hanauer, Komal Chughtai, Erin Gatza, Daniel Couriel, Steven A. Goldstein, Attaphol Pawarode, P Reddy, Mary Mansour Riwes, J. Connelly, Andrew C. Harris, Carrie L. Kitko, John E. Levine, Gregory A. Yanik, Brian Parkin, Sung Won Choi

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies

    Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies by John Magenau, Hiromi Tobai, Attaphol Pawarode, Thomas Braun, Edward Peres, Pavan Reddy, Carrie L. Kitko, Sung Won Choi, Gregory A. Yanik, David Frame, Andrew C. Harris, Harry P. Erba, Lisa Kujawski, Kojo S.J. Elenitoba‐Johnson, Jennifer Sanks, Dawn Jones, Sophie Paczesny, James L.M. Ferrara, John E. Levine, Shin Mineishi

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease

    Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease by Paul J. Martin, Barry E. Storer, Scott D. Rowley, Mary E.D. Flowers, Stephanie J. Lee, Paul A. Carpenter, John R. Wingard, Paul Shaughnessy, Marcel P. Devetten, Madan Jagasia, Joseph W. Fay, Koen van Besien, Vikas Gupta, Carrie L. Kitko, Laura Johnston, Richard T. Maziarz, Mukta Arora, Pamala A. Jacobson, Daniel Weisdorf

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study

    Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study by Carrie L. Kitko, Mukta Arora, Zachariah DeFilipp, Mohammad Abu Zaid, Antonio Di Stasi, Vedran Radojčić, Courtney B. Betts, Lisa M. Coussens, Michael L. Meyers, Hope Qamoos, Peter Ordentlich, Vinit Kumar, Christine Quaranto, Aaron Schmitt, Yu Gu, Bruce R. Blazar, Trent Wang, Amandeep Salhotra, Iskra Pusic, Madan Jagasia, Stephanie J. Lee

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Outcome of Transplantation for Acute Myelogenous Leukemia in Children with Down Syndrome

    Outcome of Transplantation for Acute Myelogenous Leukemia in Children with Down Syndrome by Johann Hitzler, Wensheng He, John Doyle, Mitchell S. Cairo, Bruce M. Camitta, Ka Wah Chan, Miguel Ángel Díaz, Christopher Fraser, Thomas G. Gross, John Horan, Alana A. Kennedy‐Nasser, Carrie L. Kitko, Joanne Kurtzberg, Leslie E. Lehmann, Tracey O’Brien, Michael A. Pulsipher, Franklin O. Smith, Mei-Jie Zhang, Mary Eapen, Paul A. Carpenter

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Plasma CXCL9 elevations correlate with chronic GVHD diagnosis

    Plasma CXCL9 elevations correlate with chronic GVHD diagnosis by Carrie L. Kitko, John E. Levine, Barry E. Storer, Xiaoyu Chai, David A. Fox, Thomas M. Braun, Daniel R. Couriel, Paul J. Martin, Mary E.D. Flowers, John A. Hansen, Lawrence Chang, Megan Conlon, Bryan Fiema, Rachel L. Morgan, Prae Pongtornpipat, Kelly Lamiman, James L.M. Ferrara, Stephanie J. Lee, Sophie Paczesny

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: